USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
21 Oct 2021 | 08:00 AM GMT

Masterclass: AI-based diagnostics - learnings from a real-world use case

Anchored by:

Zachary Tan
General Partner
AEGIS VENTURES

Participants:

Zachary Tan General PartnerAegis Ventures
Zachary Tan
General PartnerAegis Ventures
Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Camille Ridel Head of StrategyBiocorp
Camille Ridel
Head of StrategyBiocorp
Cris De Luca Partner, Digital InvestmentsSanofi Ventures
Cris De Luca
Partner, Digital InvestmentsSanofi Ventures
Devinder Chauhan CEOMacuject Pty Ltd
Devinder Chauhan
CEOMacuject Pty Ltd
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Dudi Klein Co-Founder, Managing PartnerALIVE Israel Healthtech Fund
Dudi Klein
Co-Founder, Managing PartnerALIVE Israel Healthtech Fund
George Margelis ChairAged Care Industry Information Technology Council
George Margelis
ChairAged Care Industry Information Technology Council
Johannes Munding Director, Patient Experience DesignNovartis
Johannes Munding
Director, Patient Experience DesignNovartis
LZ
Lisa Zhu Research FellowCERA
LZ
Lisa Zhu
Research FellowCERA
Sam Roberts Chief Executive OfficerNational Institute of Health and Care Excellence
Sam Roberts
Chief Executive OfficerNational Institute of Health and Care Excellence

About this Meeting

AI-based diagnostics tools for early screening have a great potential to promote prevention, prompt early initiation of treatment and improve outcomes. However, we have not seen much data showing real-world implementation of these tools yet. In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare. In this session led by Zachary & Lisa we will deep dive into: 

  •  What can AI do? How do AI-based screening programs compare to reference standards? Are there other capabilities which are only enabled by AI?
  •  Challenges in applying AI in the real-world of these tools into hospital systems, physicians workflows and referral pathways.  What else is needed to build clinicians’ trust on these systems?  
  •  How do we address these challenges? Methods to improve real-world uptake and to engage clinicians, patients and organizational stakeholders with AI-based screening tools. 
  •  AI’s future: How do we best use these tools in real-world settings, beyond tests and research studies. How do we see the field developing and growing?